Cargando…

Efficacy and pharmacokinetics of intravenous paracetamol in the critically ill patient

Detalles Bibliográficos
Autores principales:	Samson, AD, Hunfeld, NG, Touw, DJ, Melief, PH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084293/ http://dx.doi.org/10.1186/cc7571

Ejemplares similares

Intravenous paracetamol (Prodafalgan) causes hypotension in critically ill patients
por: Hersch, M, et al.
Publicado: (2004)

Intravenous paracetamol pharmacokinetics in neonates: a pooled analysis
por: Allegaert, K, et al.
Publicado: (2011)

Pharmacist clinical interventions in the ICU
por: Hunfeld, NG, et al.
Publicado: (2010)

Single-centre audit on the use of intravenous paracetamol in neonates
por: Vanhole, C, et al.
Publicado: (2008)

Pharmacokinetics of orally administered melatonin in critically ill patients
por: Moroni, B, et al.
Publicado: (2010)

Intravenous paracetamol for fever control in acute brain-injured patients: cerebral and hemodynamic effects
por: Picetti, E, et al.
Publicado: (2013)

Pharmacokinetics of oral melatonin in patients recovering from critical illness
por: Bourne, R
Publicado: (2008)

The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Covariates of intravenous paracetamol pharmacokinetics in adults
por: Allegaert, Karel, et al.
Publicado: (2014)

Antipyretics in the emergency department - intravenous paracetamol versus intramuscular diclofenac: a comparative study
por: Purayil, N, et al.
Publicado: (2014)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Effect of critical illness on the pharmacokinetics and dose-response relationship of midazolam
por: Ovakim, D, et al.
Publicado: (2012)

Pharmacokinetics of long-lasting, high-dose dexmedetomidine infusions in critically ill patients
por: Iirola, T, et al.
Publicado: (2011)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
por: Hernandez-Cardenas, CH, et al.
Publicado: (2014)

Effect of intravenous immunoglobulin in critically ill adult patients with sepsis: a meta-analysis
por: Turgeon, A, et al.
Publicado: (2006)

Gastric emptying assessment in critically ill patients with feed intolerance; comparison of (13)C octanoic acid, paracetamol and 3-O-methylglucose absorption tests
por: Chapman, M, et al.
Publicado: (2012)

Evaluation of gentamicin first-dose pharmacokinetics in septic critically ill patients: pilot study
por: Pereira, JC Gonçalves, et al.
Publicado: (2009)

Point and trend accuracy of continuous glucose monitoring using intravenous microdialysis in critically ill patients
por: Leopold, JH, et al.
Publicado: (2015)

Standards of referrals and admissions of critically ill patients to the ICU
por: Ng, A
Publicado: (2013)

Efficacy of a palliative care program in critically ill patients
por: Ribeiro, SCF, et al.
Publicado: (2011)

Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy
por: Barrasa González, H, et al.
Publicado: (2015)

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
por: Sime, Fekade B., et al.
Publicado: (2018)

Early treatment with intravenous immunoglobulins in patients with critical illness polyneuropathy: a randomized controlled, double-blinded study
por: Brunner, R, et al.
Publicado: (2012)

0716. Does intravenous iron induce oxydative stress in critically ill patients? A comparison with healthy volunteers
por: Lasocki, S, et al.
Publicado: (2014)

Effect of increasing intravenous glucose load in the presence of normoglycemia on outcome and metabolism in critically ill rabbits
por: Derde, S, et al.
Publicado: (2009)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury
por: Petejova, N, et al.
Publicado: (2013)

Single-dose pharmacokinetics of the cholesteryl sulfate complex of amphotericin B in critically ill patients with cholestatic liver failure
por: Weiler, S, et al.
Publicado: (2008)

Upper extremity thromboses in medical-surgical critically ill patients
por: Zytaruk, N, et al.
Publicado: (2011)

Copeptin and acute renal failure in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Efficacy and safety of enoxaparin as deep vein thrombosis prophylaxis in critically ill patients
por: Al-Hubail, R, et al.
Publicado: (2012)

Efficacy and utility of preemptive anti-Gr(+) coverage in selected critically ill patients
por: Todorova, VT, et al.
Publicado: (2013)

Efficacy of electrical muscle stimulation on preserving the muscle mass of critically ill patients
por: Gerovasili, V, et al.
Publicado: (2008)

Hemodynamic effects of intravenous paracetamol in critically ill children with septic shock on inotropic support
por: Nahum, Elhanan, et al.
Publicado: (2020)

Urinary TIMP-2 and IGFBP7 elevate early in critically ill postoperative patients that develop AKI
por: Honore, P, et al.
Publicado: (2015)

Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006)

Paracetamol hypersensitivity: a 5 year review
por: Malheiro, Daniela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oom3pg5k3nic8llcabualghdu4